Application

15465091 · DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

Filed 2017-03-21 · Abandoned The official file ↗ · Art unit 1621 · Examiner Kathrien Ann Hartsfield Hard · CPC A61K 31/137 · Novartis AG · NOVARTIS PHARMACEUTICAL CORPORATION

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

8.6 mo

to disposition 16.1 mo

Statutes raised

103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.